Evidence map›Paper›PMID 28434065›Full record

ArticleVirus genes2017

Alternative reverse genetics system for influenza viruses based on a synthesized swine 45S rRNA promoter.

Kai Wang, Qi Huang, Zhiwei Yang, Kezong Qi, Hongmei Liu, Hongjun Chen

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Virus genes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Influenza Reverse Genetics-Historical Perspective.Cold Spring Harbor perspectives in medicine · 2021
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kai WangShanghai Veterinary Research Institute, CAAS, Shanghai, 200241, China.
Qi HuangShanghai Veterinary Research Institute, CAAS, Shanghai, 200241, China.
Zhiwei YangShanghai Veterinary Research Institute, CAAS, Shanghai, 200241, China.
Kezong QiShanghai Veterinary Research Institute, CAAS, Shanghai, 200241, China.
Hongmei LiuCollege of Animal Science and Technology, Anhui Agricultural University, Hefei, 230036, China. 1030775529@qq.com.
Hongjun ChenShanghai Veterinary Research Institute, CAAS, Shanghai, 200241, China. vetchj@shvri.ac.cn.
Anhui Agricultural University · CNShanghai Veterinary Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We generated an alternative reverse genetics (RG) system based on a synthesized swine 45S rRNA promoter to rescue the H3N2 subtype swine influenza virus. All eight flanking segment cassettes of A/swine/Henan/7/2010 (H3N2) were amplified with ambisense expression elements from RG plasmids. All segments were then recombined with the pHC2014 vector, which contained the synthesized swine 45S rRNA promoter (spol1) and its terminal sequence (t1) in a pcDNA3 backbone. As a result, we obtained a set of RG plasmids carrying the corresponding eight-segment cassettes. We efficiently generated the H3N2 virus after transfection into 293T/PK15, PK15, and 293T cells. The efficiency of spol1-driven influenza virus rescue in PK15 cells was similar to that in 293T cells by titration using the human pol1 RG system. Our approach suggests that an alternative spol1-based RG system can produce influenza viruses.

Indexed as

Promoter Regions, GeneticAnimalsHumansInfluenza A Virus, H3N2 SubtypeOrthomyxoviridae InfectionsPlasmidsReverse GeneticsRNA, RibosomalRNA, ViralSequence Analysis, DNASwineSwine DiseasesRNA, RibosomalRNA, ribosomal, 45SRNA, Viral45 s rRNA promoterInfluenza virusRescueReverse geneticsSwine

Identifiers

PMID28434065
OpenAlexW2606755173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.